Lenacapavir API
COA 1 Inquiries
2189684-44-2
Pharmaceutical Grade
99%
南通港
1g/100g/1Kg
2026-04-16
Medetomidine,Medetomidine hydrochloride,D-Lysergic Acid Methyl Ester,SR17018,Fluralaner,GS-441524
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceLenacapavir is under investigation in clinical trial NCT04150068 (Study to Evaluate the Safety and Efficacy of Lenacapavir in Combination With an Optimized Background Regimen in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance).
HIV-1 capsid inhibitor GS-6207 (lenacapavir) is a drug being developed by Gilead Sciences, Inc. It is a first-in-class, oral HIV-1 capsid inhibitor.CertificatesBasic Info-
Product Name:
Lenacapavir
Other Name:GS-6207;Lenacapavir;1H-Cyclopropa[3,4]cyclopenta[1,2]pyrazole-1-acetamide, N-[(1S)-1-[3-[4-chloro-3-[(methylsulfonyl)amino]-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl]-6-[3-methyl-3-(methylsulfonyl)-1-butyn-1-yl]-2-pyridinyl]-2-(3,5-difluorophenyl)ethyl]-5,5-difluoro-3b,4,4a,5-tetrahydro-3-(trifluoromethyl)-, (3bS,4aR)-;13C,2H3]-Lenacapavir , isomeric mixture;MT-4,Inhibitor,antiretroviral,Lenacapavir,inhibit,GS 6207,capsid,Human immunodeficiency virus,HIV,GS6207,HIV-1,PBMCs;1H-Cyclopropa[3,4]cyclopenta[1,2-c]pyrazole, N-[(1S)-1-[3-[4-chloro-3-[(methylsulfonyl)amino]-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl]-6-[3-methyl-3-(methylsulfonyl)-1-butyn-1-yl]-2-pyridinyl]-2-(3,5-difluorophenyl)ethyl]-5,5-difluoro-3b,4,4a,5-tetrahydro-3-(trifluoromethyl)-, (3bS,4aR)-;Sunitinib Impurity 72;13C,2H3]-Lenacapavir (Major),isomers mixture
CAS No.:2189684-44-2
Molecular Formula:C39H32ClF10N7O5S2
InChIKeys:BRYXUCLEHAUSDY-WEWMWRJBSA-N
Molecular Weight:968.28
Exact Mass:967.1435188
UNII:A9A0O6FB4H
Color/Form:White to light yellow
Categories:
Characteristics-
Density:
1.62±0.1 g/cm3(Predicted)
PKA:4.63±0.30(Predicted)
Critical Temperature & Pressure:Store at -20°C
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Medetomidine,Medetomidine hydrochloride,D-Lysergic Acid Methyl Ester,SR17018,Fluralaner,GS-441524
-
Location:
RONGSHENG BEIYUANDAJIE 9, LICHENG DISTRICT,JINAN, SHANDONG CHINA
-
Payment Terms:
TT against copy of documents,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2022
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted 
South Korea
2189684-44-2
10 G Dec 2, 2024 Post an enquiry for this product
More from this Seller
-
-
![Jionoside A1 98% Purity Natural Phenylethanoid Glycoside Reference Standard CAS 120444-60-2 HPLC Grade Small Molecule Compound]( "Jionoside A1 98% Purity Natural Phenylethanoid Glycoside Reference Standard CAS 120444-60-2 HPLC Grade Small Molecule Compound")
-
Jionoside A1 98% Purity Natural Phenylethanoid Glycoside Reference Standard CAS 120444-60-2 HPLC Grade Small Molecule Compound
Research Grade / 98%
$64-70/G FOB
-
-
-
![Diantimony pentoxide cas 1314-60-9 purity 99% crystal powder Fire retardant]( "Diantimony pentoxide cas 1314-60-9 purity 99% crystal powder Fire retardant")
-
Diantimony pentoxide cas 1314-60-9 purity 99% crystal powder Fire retardant
Reagent Grade / 99%
-
-
-
![cas 2666932-55-2 reagent]( "cas 2666932-55-2 reagent")
-
cas 2666932-55-2 reagent
Reagent Grade / 99%
-
![N-[[4-(2,2-Dicyano-1-methoxyvinyl)phenyl]methyl]-5-fluoro-2-methoxybenzamide CAS2764851-04-7 Pirtobrutinib Intermediate for Pharmaceutical Research kr](https://file.echemi.com/fileManage/upload/goodpicture/20251013/7-chloro-2-5-dimethyl-1-2-4triazolo1-5-apyrimidine-cas-80812-36-8-white-powder-support-customized_b20251013141146340.png "N-[[4-(2,2-Dicyano-1-methoxyvinyl)phenyl]methyl]-5-fluoro-2-methoxybenzamide CAS2764851-04-7 Pirtobrutinib Intermediate for Pharmaceutical Research kr")
